The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

Nine percent of Americans have diagnosed diabetes.  That is an estimated 29.1 million people.  Due to those numbers, the diabetic prescription drug market is hugely successful (insert profitable here, as well).  Drug makers are constantly looking to invent the next greatest medicine to capitalize on the available profits from sales to diabetic consumers.

Invokana® (or canagliflozin) is supposed to lower blood sugar in adults with type 2 diabetes.  One of the newer diabetes drugs on the market, Invokana®, is a new age prescription drug in the form of a once daily pill. Invokana® is made by Janssen Pharmaceuticals, part of Johnson & Johnson.

Invokana® is just one of multiple prescription drugs known as SLGT2 Inhibitors.  SLGT2 stands for sodium glucose cotransporter 2.  By inhibiting the patient’s SLGT2, these drugs lower blood sugar levels in adults with type 2 diabetes when used in conjunction with proper dieting and exercise.  Invokana® and the other SLGT2 inhibitors cause glucose (or blood sugar) to pass through the kidneys and urine.

International Investigations of Invokana® and Other SLGT2 Inhibitors

The United States Food & Drug Administration warned on May 15, 2015 that Invokana® could cause ketoacidosis in adults with Type 2 Diabetes.

Now, Canada has joined the investigation by announcing Health Canada (the Canadian equivalent of our FDA) will also conduct an investigation in to Invokana® and the other SLGT2 Inhibitors.

The European Medicines Agency took the lead on investigating Invokana® and SLGT2 Inhibitors by announcing their plan to look into a possible link between the drugs and ketoacidosis.  According to the EMA, 101 people worldwide have developed ketoacidosis while on SLGT2 Inhibitors such as Invokana® to treat adult onset Type 2 Diabetes.

Invokana® Lawsuits Possible

Given the number of inquiries coming in to my firm from across the nation, it is very possible that legal claims will begin to be filed pertaining to Invokana® and the following Type 2 Diabetes medicines:

  • Invokamet®
  • Glyxambi®
  • Jardiance®
  • Farxiga®
  • Xigduo XR®

If you or a loved one has taken these drugs while treating Type 2 Diabetes and suffered one of the following disorders, there may be help provided to you under the civil justice system.

  • Ketoacidosis; o
  • Heart attack; or
  • Kidney failure

The investigations in to the above drugs are still ongoing.  However, getting in contact with a doctor as soon as possible after any of these adverse events is recommended.

Atlanta attorney Cade Parian represents citizens nationwide who have been injured by defective or dangerous prescription drugs.

Comments for this article are closed.